NEOGEN CORP

NEOGEN insider sales reflect routine vesting, while CEO and CFO buys confirm confidence; the company’s 110% YTD gain and diagnostics focus signal strong upside.

Neogen Corp insider trading: C.A.O. John Moylan boosts holdings 8.5 % with balanced buys/sells at $9.53, signaling cautious optimism amid 56 % YTD earnings growth. Click to see how it could impact the company’s future.

Neogen CEO’s steady insider buys signal confidence amid volatility; discover why a modest purchase at $9.33 may hint at future upside.